Cite

HARVARD Citation

    Taskar, K. et al. (2022). Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective. Clinical pharmacology & therapeutics. 112 (3), pp. 573-592. [Online]. 
  
Back to record